Allmed Solutions Ltd engages in the development, manufacture, and marketing of minimally invasive products in various medical disciplines in Israel and internationally. The company offers medical devices for the treatment of type 2 diabetes in obese and overweight patients; and ProCatid system, a distal embolic protection system comprised of an independent filter unit that can be delivered, locked, and deployed on any commercially marketed guide wires. It is also involved in the development of mitral valve regurgitation solution. The company was formerly known as Allium Medical Solutions Ltd. Allmed Solutions Ltd was incorporated in 2004 and is based in Caesarea, Israel.